Policymakers are increasingly recognizing that reclassifying certain substances can unlock significant research opportunities. As noted in recent policy discussions, opening up research pathways requires structural regulatory changes—without reclassification, critical scientific investigations simply can't move forward. This approach reflects a broader trend toward removing barriers that stifle innovation and discovery. When regulations adapt to enable rather than restrict, entire industries and research communities benefit from the freedom to explore new frontiers.